$13+ Billion 3D Medical Imaging Devices Global Market to 2030 – Identify Growth Segments for Investment – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “3D Medical Imaging Devices Global Market Report 2021: COVID-19 Growth and Change to 2030” report has been added to ResearchAndMarkets.com’s offering.
This report provides strategists, marketers and senior management with the critical information they need to assess the global 3d medical imaging market.
The global 3D medical imaging devices market is expected to grow from $13.67 billion in 2020 to $14.52 billion in 2021 at a compound annual growth rate (CAGR) of 6.2%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $19.58 billion in 2025 at a CAGR of 8%.
Companies Mentioned
- GE Healthcare
- Royal Philips
- Siemens AG
- The Esaote Group
- Intrasense SA
- Materialise NV
- Toshiba Group
- Samsung Medison Co Ltd
- Shimadzu Corporation
- Analogic Corporation
- Digirad Corporation
- Del Medical Systems Group, Inc.
- Hologic Inc.
- Carestream Health Inc.
- Depuy Synthes Companies
- Ambra Health
- Fovia
- Mach7 Technologies Ltd.
- Medtronic Inc
- Barco NV
- TomTec Imaging Systems GmbH
- FUJIFILM
- Carestream Health Inc
- Del Medical Systems
- Digirad Corporation
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3-5 working days of order.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider 3d medical imaging market, and compares it with other markets.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
- Market segmentations break down market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
- The 3d medical imaging market section of the report gives context. It compares the 3d medical imaging market with other segments of the 3d medical imaging market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, 3d medical imaging indicators comparison.
The 3D medical imaging market covered in this report is segmented by type into ultrasound, X-ray, CT scan, others. It is also segmented by end user into diagnostic centers, hospitals, research centers and by application into gynecology and obstetrics, cardiology, neurology, orthopedics, oncology.
3D medical imaging device manufacturers are increasingly investing in Artificial Intelligence (AI) to improve the diagnosis by giving accurate, hard-number measurements. AI provides efficiency in medical imaging, particularly when it comes to detecting organs or anomalies. For instance, by combining image visualization and AI, cardiologists can measure ejection fraction with high precision and in a much shorter period of time. Ejection fraction is a measurement of the percentage of blood leaving the heart each time when it contracts. According to a report by Signify Research, in January 2019, capital investments in start-up companies developing 3D medical imaging AI solutions reached almost $580 million in 2018 from $270 million in 2017.
In February 2020, Alphatec Holdings, Inc. (“ATEC” or the “Company”) acquired EOS imaging, SA for a purchase price of about $88 million. With this acquisition ATEC will integrat spine imaging and anatomical modelling for better operative performance and expected to significantly increase the demand for ATEC hardware and EOS systems. EOS Imaging is a France based medical device company leading in orthopedic medical imaging solutions.
For more information about this report visit https://www.researchandmarkets.com/r/vbuq5s
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
